Significantly increased risk of QT interval prolongation and Torsades de Pointes, leading to potentially fatal arrhythmias.
Concomitant use is contraindicated. Avoid this combination.
Source: DDInter
Fluoroquinolone · Antibiotic
The quinolone antibiotics target bacterial DNA gyrase and topoisomerase IV. For many gram-positive bacteria, topoisomerase IV is the primary target, while for many gram-negative microbes, DNA gyrase is the primary target. Inhibition of these enzymes prevents the continuous introduction of negative supercoils into DNA and the separation of interlinked daughter DNA molecules, which are crucial for bacterial DNA replication and transcription.
Significantly increased risk of QT interval prolongation and Torsades de Pointes, leading to potentially fatal arrhythmias.
Concomitant use is contraindicated. Avoid this combination.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy.
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung·Verified: 2026-05-13 · House clinical team